Performance of a Four-Antigen <i>Staphylococcus aureus</i> Vaccine in Preclinical Models of Invasive <i>S. aureus</i> Disease.

Scully, Ingrid L; Timofeyeva, Yekaterina; Illenberger, Arthur; Lu, Peimin; Liberator, Paul A; Jansen, Kathrin U; Anderson, Annaliesa S

Performance of a Four-Antigen Staphylococcus aureus Vaccine in Preclinical Models of Invasive S. aureus Disease.

Scully, Ingrid L; Timofeyeva, Yekaterina; Illenberger, Arthur; Lu, Peimin; Liberator, Paul A; Jansen, Kathrin U; Anderson, Annaliesa S.

Afiliação

Scully IL; Pfizer Vaccine Research & Development, Pearl River, NY 10965, USA.
Timofeyeva Y; Pfizer Vaccine Research & Development, Pearl River, NY 10965, USA.
Illenberger A; Pfizer Vaccine Research & Development, Pearl River, NY 10965, USA.
Lu P; Pfizer Vaccine Research & Development, Pearl River, NY 10965, USA.
Liberator PA; Pfizer Vaccine Research & Development, Pearl River, NY 10965, USA.
Jansen KU; Pfizer Vaccine Research & Development, Pearl River, NY 10965, USA.
Anderson AS; Pfizer Vaccine Research & Development, Pearl River, NY 10965, USA.

Microorganisms ; 9(1)2021 Jan 15.

Article em En | MEDLINE | ID: mdl-33467609

Palavras-chave

ClfA; MntC; SA4Ag vaccine; Staphylococcus aureus; animal models; conjugated polysaccharide; invasive disease; protection; sepsis; surgery-associated infection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article